Literature DB >> 2994661

Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pig.

I Maridonneau-Parini, V Lagente, J Lefort, J Randon, F Russo-Marie, B B Vargaftig.   

Abstract

Guinea-pig alveolar macrophages are activated in the presence of PAF-acether (PAF), as shown by O2.- production, suggesting that these cells, abundant in the lungs, are involved in PAF-induced bronchoconstriction. Alveolar macrophages collected after in vivo desensitization to the bronchoconstrictor effect of PAF became refractory to it in vitro, whereas the O2.- production in response to f-met-leu-phe persisted, although it was diminished suggesting a partial cross-desensitization. A similar desensitization to PAF was also observed in alveolar macrophages in vitro, demonstrating a stimulus-specific process. This study suggests that alveolar macrophages may be involved in bronchoconstriction induced by aerosol of PAF.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994661     DOI: 10.1016/0006-291x(85)91767-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Effects of platelet activating factor on airway calibre, airway responsiveness, and circulating cells in asthmatic subjects.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1989-02       Impact factor: 9.139

2.  Paf-induced release of spasmogens from guinea-pig lungs.

Authors:  S Jancar; P Thériault; M Lauzière; P Braquet; P Sirois
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

3.  Inhibition of O2- generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages.

Authors:  I Maridonneau-Parini; M Errasfa; F Russo-Marie
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

4.  Inhaled budesonide fails to inhibit the PAF-induced increase in plasma leukotriene B4 in man.

Authors:  M M Nieminen; E K Moilanen; M O Koskinen; J I Karvonen; L Tuomisto; T J Metsä-Ketelä; H Vapaatalo
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

5.  Pharmacological modulation of Paf-induced rat pleurisy and its role in inflammation by zymosan.

Authors:  M A Martins; P M Silva; H C Faria Neto; P T Bozza; P M Dias; M C Lima; R S Cordeiro; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

6.  Inhibition by cardiolipins of platelet-activating factor-induced rabbit platelet activation.

Authors:  D Tsoukatos; C A Demopoulos; A D Tselepis; M C Moschidis; A Donos; A Evangelou; J Benveniste
Journal:  Lipids       Date:  1993-12       Impact factor: 1.880

7.  Body temperature modulates the effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit.

Authors:  M M Nieminen; M Hill; C G Irvin
Journal:  Agents Actions       Date:  1991-03

8.  Platelet-activating factor-induced contraction of guinea-pig lung parenchymal strips: possible involvement of arachidonate metabolites.

Authors:  M Del Monte; A Subissi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

9.  Interference of the Paf antagonist Ro 19-3704 with Paf and antigen-induced bronchoconstriction in the guinea-pig.

Authors:  V Lagente; S Desquand; P Hadvary; M Cirino; A Lellouch-Tubiana; J Lefort; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

10.  Inhibition of human immunodeficiency virus type-1 (HIV-1) glycoprotein-mediated cell-cell fusion by immunor (IM28).

Authors:  Donatien Mavoungou; Virginie Poaty-Mavoungou; Marie-Yvonne Akoume; Brice Ongali; Elie Mavoungou
Journal:  Virol J       Date:  2005-02-11       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.